Treatment Registry

Company

MediRX

Recorded offers and program terms appear below. Check eligibility, billing periods and separate fees before comparing totals.

Published by Treatment Registry · Latest research

  • 5 programs
  • 2 identified molecules
  • 15 readings

Read from medirx.org; latest program check October 2026. Individual programs and sources may have earlier verification dates.

Go to MediRX

Visit MediRX

We earn nothing from this link. It opens MediRX's website without a paid referral.

Terms

Pharmacy

Published partner network: Red Rock Pharmacy; HealthWarehouse; Precision Compounding Pharmacy; Triad Rx. The assigned dispenser varies and is not established here.

Across recorded programs · Evidence: October 2026

Membership

None. “No membership fees — everything you need is included”

Across recorded programs · Evidence: October 2026

Consultation fee

Not disclosed

Across recorded programs · Evidence: October 2026

States

Not disclosed

Across recorded programs · Evidence: October 2026

Programs

More columns to the right? Scroll across the table to see all details.

EntryProgramFormRecorded price
with its payment basis
Link
EntryTR-0701ProgramCompounded semaglutideFormNot recordedRecorded price$179
Published figure · Homepage hero banner, "Most Affordable" tier

Initial payment not verified

Recurring price conditions not established

Record
EntryTR-0702ProgramCompounded tirzepatideFormNot recordedRecorded price$399
Published figure · Homepage hero banner, "Popular" tier

Initial payment not verified

Recurring price conditions not established

Record
EntryTR-0703ProgramBrand semaglutideFormNot recordedRecorded price$399
Published figure · Homepage hero banner, "Name Brand" Ozempic tier

Initial payment not verified

Recurring price conditions not established

Record
EntryTR-0704ProgramOral semaglutideFormOral tabletRecorded price$249
Published figure · Semaglutide Oral Tablets

Initial payment not verified

Recurring price conditions not established

Record
EntryTR-0705ProgramCompounded tirzepatideFormOral tabletRecorded price$279
Published figure · Tirzepatide Oral Tablets

Initial payment not verified

Recurring price conditions not established

Record

Notes

Pricing details, service terms and questions to confirm before enrolling.

October 2026

  1. 1. MediRx offers online review where permitted and live video or phone consultation where state rules require it. Its public starting-price cards do not state a billing interval, and navigation prices differ from the cards. Published nationwide service language also says some services are unavailable in some states. Confirm the medication, amount due, dispensing pharmacy and eligibility before payment.

October 2026

  1. 2. Correction to the earlier price interpretation: the saved twelve-month semaglutide quote establishes a monthly equivalent, not the initial amount charged. The unsupported initial invoice is marked unverified pending confirmation. Other earlier advertised prices remain historical; this correction does not establish a price change or a fresh reading of MediRX's site. Source: https://medirx.org/weight-loss-solutions
Show 1 more noteHide 1 more note

September 2026

  1. 3. Site publishes three separate, mutually contradictory price sets for the same products: the homepage hero banner (semaglutide $179, tirzepatide $399), the homepage's own pricing section a few screens down (semaglutide $149, tirzepatide $199), and the /weight-loss-solutions page (semaglutide $196/mo on a 12-month plan, tirzepatide $49 on a 3-month plan). All three are recorded above rather than picking one. The 'Name Brand Ozempic® Injection' card is labeled Name Brand but its description text is copy-pasted from the tirzepatide card ('Same active ingredient as Mounjaro® and Zepbound®'), an apparent site bug; recorded as brand semaglutide based on the product name (Ozempic) rather than the mismatched description. The homepage also shows 'NEW YEAR PROMO Only $149' though today is September -- an expired promotion still on the page. The /weight-loss-solutions page additionally contains leftover template copy referencing an unrelated brand ('Rejuve') and unrelated services (testosterone therapy, ED treatment 'Mounjaro®' mislabeled as a testosterone product), suggesting reused boilerplate never fully customized for MediRX. Prescriber sync/async could not be determined with confidence: OpenLoop disclaimer says a clinician 'will meet with the individual after checkout' but the intake copy describes an asynchronous review ('Our team of licensed professionals will review your information and provide approval'), so this was left not-found rather than guessed.

Understand the terms

Before you act

Cite this

Treatment Registry. (2026). MediRX: recorded programs and prices. Last verified October 2026. Retrieved [your access date], from https://treatmentregistry.com/providers/medirx